X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (219) 219
medicin och hälsovetenskap (219) 219
clinical medicine (191) 191
cancer och onkologi (189) 189
klinisk medicin (189) 189
cancer and oncology (187) 187
humans (182) 182
female (170) 170
oncology (118) 118
prognosis (118) 118
breast cancer (108) 108
middle aged (106) 106
adult (94) 94
breast neoplasms - pathology (82) 82
index medicus (81) 81
aged (74) 74
cancer (54) 54
breast neoplasms - genetics (45) 45
aged, 80 and over (44) 44
breast neoplasms - metabolism (43) 43
gene expression (41) 41
breast neoplasms - mortality (40) 40
immunohistochemistry (38) 38
expression (34) 34
flow cytometry (34) 34
breast neoplasms - drug therapy (33) 33
disease-free survival (33) 33
medicine (33) 33
male (32) 32
receptors, estrogen - analysis (32) 32
survival (32) 32
tumors (32) 32
biomarkers (27) 27
follow-up studies (27) 27
neoplasm staging (27) 27
receptors, estrogen - metabolism (27) 27
research (27) 27
carcinoma (26) 26
ploidies (26) 26
receptors, progesterone - analysis (26) 26
survival analysis (26) 26
tamoxifen (26) 26
biomarkers, tumor - analysis (25) 25
tamoxifen - therapeutic use (25) 25
analysis (24) 24
cells (24) 24
estrogen (24) 24
metastasis (24) 24
pathology (24) 24
surgery (24) 24
medicin (22) 22
multivariate analysis (22) 22
research article (22) 22
s-phase fraction (22) 22
chemotherapy, adjuvant (20) 20
dna, neoplasm - analysis (20) 20
estrogen-receptor (20) 20
gene expression profiling (20) 20
biomarkers, tumor - metabolism (19) 19
carcinomas (19) 19
cell biology (19) 19
proliferation (19) 19
risk factors (19) 19
animals (18) 18
breast neoplasms - diagnosis (18) 18
cohort studies (18) 18
genetic aspects (18) 18
ploidy (18) 18
dna (17) 17
lymphatic metastasis (17) 17
reproducibility of results (17) 17
breast neoplasms - chemistry (16) 16
medical prognosis (16) 16
menopause (16) 16
oligonucleotide array sequence analysis (16) 16
s phase (16) 16
tissue array analysis (16) 16
adjuvant tamoxifen (15) 15
antineoplastic agents, hormonal - therapeutic use (15) 15
chemotherapy (15) 15
diagnosis (15) 15
follow-up (15) 15
kaplan-meier estimate (15) 15
proportional hazards models (15) 15
time factors (15) 15
care and treatment (14) 14
classification (14) 14
neoplasm metastasis (14) 14
premenopause (14) 14
recurrence (14) 14
risk (14) 14
survival rate (14) 14
women (14) 14
gene expression regulation, neoplastic (13) 13
patients (13) 13
physiological aspects (13) 13
proteins (13) 13
treatment outcome (13) 13
cancer patients (12) 12
cell line, tumor (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 08/2015, Volume 7, Issue 8, pp. 1034 - 1047
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e38863
Similar to other malignancies, urothelial carcinoma (UC) is characterized by specific recurrent chromosomal aberrations and gene mutations. However, the... 
INACTIVATION | BLADDER-CANCER | SIGNATURES | TRANSITIONAL-CELL CARCINOMA | ARRAY-CGH | COPY NUMBER | BIOLOGY | IMBALANCES | HYBRIDIZATION | MUTATIONS | TUMORS | Immunohistochemistry | Proto-Oncogene Proteins c-mdm2 - genetics | Oligonucleotide Array Sequence Analysis | Tissue Array Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Gene Regulatory Networks | Tumor Suppressor Protein p53 - genetics | Neoplasm Grading | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Genomics - methods | Carcinoma, Transitional Cell - genetics | Kaplan-Meier Estimate | Gene Expression Profiling - methods | Carcinoma, Transitional Cell - pathology | Comparative Genomic Hybridization | Chromosome Aberrations | Aged | Mutation | Neoplasm Staging | Cluster Analysis | Carcinoma | Gene mutations | Genes | Genomics | Cytogenetics | Development and progression | Genetic aspects | Genomes | Gene expression | Cancer | Profiling | Circuits | p53 Protein | Raf protein | Oncology | Urology | Subgroups | Alterations | Tiling | Localization | Urothelial carcinoma | Bioinformatics | Chromosomes | Deoxyribonucleic acid--DNA | MDM2 protein | Melanoma | Bladder cancer | Chromosome 1 | Studies | Amplification | Point mutation | Aberration | PTEN protein | Chromosome aberrations | Tumors | Fibroblast growth factor receptors | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi | Deoxyribonucleic acid | DNA
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2012, Volume 18, Issue 12, pp. 3377 - 3386
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0150977
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2010, Volume 120, Issue 2, pp. 491 - 498
Triple-negative breast cancer (TNB) has poor prognosis and moreover patients with TNB do not benefit from established targeted drugs with endocrine therapy or... 
Prognosis | Medicine & Public Health | Oncology | Gene copy number | Vascular endothelial growth factor receptor 2 | Epidermal growth factor receptor | Triple-negative breast cancer | PHENOTYPE | PATTERNS | EGFR | CETUXIMAB | ONCOLOGY | BASAL-LIKE SUBTYPE | KIT | CARCINOMAS | ADJUVANT TAMOXIFEN | EXPRESSION | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Follow-Up Studies | Receptor, ErbB-2 - genetics | Tissue Array Analysis | Humans | Middle Aged | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Vascular Endothelial Growth Factor Receptor-2 - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Vascular Endothelial Growth Factor Receptor-2 - biosynthesis | Chemotherapy, Adjuvant | Receptor, Epidermal Growth Factor - biosynthesis | Receptor, ErbB-2 - biosynthesis | Receptors, Estrogen - genetics | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Gene Dosage | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Tamoxifen - therapeutic use | Receptors, Estrogen - biosynthesis | Biomarkers, Tumor - genetics | Neoplasm Staging | Receptors, Progesterone - biosynthesis | Care and treatment | Epidermal growth factor | Analysis | Menopause | Fluorescence | Breast cancer | Tamoxifen | Biological markers | Vascular endothelial growth factor | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2018, Volume 118, Issue 4, pp. 480 - 488
Background: Transcriptomic profiles have shown promise as predictors of response to neoadjuvant chemotherapy in breast cancer (BC). This study aimed to explore... 
CARBOPLATIN | immune | PREDICTOR | tumour-infiltrating lymphocytes | SIGNATURE | DOCETAXEL | ESTROGEN-RECEPTOR | TUMOR-INFILTRATING LYMPHOCYTES | IMPACT | MOLECULAR PORTRAITS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | RECURRENCE | advanced breast cancer | chemosensitivity | gene expression | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Paclitaxel - pharmacology | Breast Neoplasms - immunology | Humans | Middle Aged | Capecitabine - pharmacology | Gene Expression Profiling - methods | Treatment Outcome | Epirubicin - administration & dosage | Gene Regulatory Networks - drug effects | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Biopsy, Fine-Needle | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Survival Analysis | Female | Gene Expression Regulation, Neoplastic - drug effects | Paclitaxel - administration & dosage | Epirubicin - pharmacology | Enrichment | Immune response | Transcription | Breast cancer | Gene expression | Patients | Subgroups | Confidence intervals | Signaling | Chemotherapy | Biopsy | Lymphocytes | Genetic analysis | Tumors | Cancer | Immune system | Clinical Study | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0179775
Histological grade is one of the most commonly used prognostic factors for patients diagnosed with breast cancer. However, conventional grading has proven... 
RECOMBINANT ANTIBODY MICROARRAYS | DESIGN | BIOMARKER DISCOVERY | MULTIDISCIPLINARY SCIENCES | CARCINOMAS | RECEPTOR | GENERATION | NOTTINGHAM MODIFICATION | EXPRESSION | REPRODUCIBILITY | PROGRESSION | Prognosis | Neoplasm Grading - methods | Breast Neoplasms - immunology | Humans | Middle Aged | Neoplasm Proteins - immunology | Neoplasm Proteins - metabolism | Breast Neoplasms - metabolism | Pilot Projects | Breast Neoplasms - pathology | Biomarkers, Tumor - metabolism | Protein Array Analysis | Adult | Female | Aged | Single-Chain Antibodies | Biomarkers, Tumor - immunology | Care and treatment | Usage | Breast cancer | Diagnosis | Research | Tumor proteins | Mass spectrometry | Slopes | Panels | Profiling | Kinases | Proteins | Heterogeneity | Biological effects | Quality | Classification | Bioindicators | Signatures | Immune system | Recombinant | Evaluation | Cytokines | Immunoregulation | Decision making | Cyclin-dependent kinases | Antibody microarrays | Patients | Gene amplification | Medical prognosis | Proteomics | Biomarkers | Breast | Scientific imaging | Tumors | Cancer | Biological Sciences | Breast tumors | Immunologi | Medical and Health Sciences | Microarrays | Medicin och hälsovetenskap | Antibodies | Histology | Klinisk medicin | Breast Cancer | Recombinant proteins | Enzyme-linked immunoassays | Clinical Medicine | Naturvetenskap | Immunology | Biologi | Natural Sciences | Cancer and Oncology | Cancer och onkologi
Journal Article
BREAST CANCER RESEARCH AND TREATMENT, ISSN 0167-6806, 06/2019, Volume 175, Issue 2, pp. 305 - 316
PurposeAccording to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, progesterone receptor (PR) and Nottingham histological grade... 
Androgen receptor (AR) | Prognostic biomarkers | LONG-TERM | PROTEIN | MARKER | TAMOXIFEN | MEMBRANE | Gene expression | CANCER | Invasive lobular carcinoma (ILC) | ONCOLOGY | ANDROGEN RECEPTORS | RECURRENCE | Amplified in breast cancer 1 (AIB1) | G protein-coupled estrogen receptor (GPER) | EXPRESSION | DUCTAL CARCINOMA | Preclinical Study
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2013, Volume 183, Issue 3, pp. 681 - 691
Journal Article